HER3-targeting antibody-drug conjugate
This page covers all HER3-targeting antibody-drug conjugate drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HER3.
Targets
Phase 2 pipeline (1)
- HER3-DXd · Merck Sharp & Dohme LLC · Oncology
HER3-DXd is a HER3-targeting antibody-drug conjugate.
Patent intelligence
- her3 targeting antibody drug conjugate patent landscape — aggregated cliff calendar, attackable patents, originator estates